Search - tctmd.com

Displaying 1 - 20 of 404

Sort: Relevancy | Date

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

News Daily News

New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community

January 12, 2026

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

News Daily News

Year in Review: Reimbursement, Funding Cuts Mark Top Policy & Practice News

Yael L. Maxwell

December 26, 2025

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

News Daily News

Aprocitentan Effective in CKD Patients With Resistant Hypertension: PRECISION

December 16, 2025

Front-of-Package Nutrition Info Backed by ACC to Improve CV Health

News Daily News

Front-of-Package Nutrition Info Backed by ACC to Improve CV Health

December 10, 2025

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

November 21, 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

November 14, 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

News Conference News AHA 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

November 12, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

Presentation TCT 2025

TCT 492: Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular Outcomes Post-PCI in Patients with Diabetes: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 28, 2025

Presentation TCT 2025

TCT 764: Impact of Sodium- Glucose Cotransporter 2 Inhibitors on Outcomes of Transcatheter Aortic Valve Replacement: Meta-Analysis

Presenter: Ritu Yadav

October 27, 2025

Presentation TCT 2025

TCT 94: Impact of Sodium-Glucose Cotransporter-2 Inhibitors On Contrast-Induced Acute Kidney Injury in Diabetic Patients Treated with Percutaneous Coronary Intervention

Presenter: Priyesh Thakurathi

October 27, 2025

Presentation TCT 2025

TCT 756: Sodium-Glucose Co-Transporter 2 Inhibitors and Clinical Outcomes After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 27, 2025

Presentation TCT 2025

TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database

Presenter: Aymen Ahmed

October 26, 2025

Presentation TCT 2025

TCT 752: Sodium-Glucose Co-Transporter 2 Inhibitors use and Outcomes in Heart Failure patients undergoing Mitra Clip: A Real World Propensity Matched Analysis

Presenter: Aymen Ahmed

October 25, 2025

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

News Daily News

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

October 07, 2025

Too Few HF Patients on Guideline-Directed Medical Therapy in VA System

News Conference News HFSA 2025

Too Few HF Patients on Guideline-Directed Medical Therapy in VA System

Yael L. Maxwell

October 06, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.